Texas Attorney General Ken Paxton on Nov. 19 announced that his office had reached a $41.5 million settlement with Pfizer and Tris Pharma to resolve a November 2023 lawsuit regarding the companies’ distribution of the attention deficit/hyperactivity disorder (ADHD) medication Quillivant to children.
Paxton sued the pharmaceutical companies and Tris Pharma CEO Ketan Mehta, alleging that they knowingly provided adulterated Quillivant XR to Texas children on Medicaid despite flawed manufacturing practices that led to multiple quality-control failures.
According to the lawsuit, Tris Pharma allegedly altered its testing methods to ensure the ADHD drug would pass federal regulations and could be sold in Texas, in violation of the Texas Health Care Program Fraud Prevention Act….